Cleared Special

K143678 - NvisionVLE Imaging System, NvisionVLE Optical Probe, NvisionVLE Inflation Accessory (FDA 510(k) Clearance)

Feb 2015
Decision
44d
Days
Class 2
Risk

K143678 is an FDA 510(k) clearance for the NvisionVLE Imaging System, NvisionVLE Optical Probe, NvisionVLE Inflation Accessory. This device is classified as a System, Imaging, Optical Coherence Tomography (oct) (Class II - Special Controls, product code NQQ).

Submitted by Ninepoint Medical, Inc. (Cambridge, US). The FDA issued a Cleared decision on February 6, 2015, 44 days after receiving the submission on December 24, 2014.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 892.1560. This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging..

Submission Details

510(k) Number K143678 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received December 24, 2014
Decision Date February 06, 2015
Days to Decision 44 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NQQ - System, Imaging, Optical Coherence Tomography (oct)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1560
Definition This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging.

Similar Devices - NQQ System, Imaging, Optical Coherence Tomography (oct)

All 9
LIA Console (542-7)
K251730 · Leadoptik, Inc. · Dec 2025
HyperVue™ Imaging System - Integrated
K253101 · Spectrawave, Inc. · Dec 2025
deepLive (OSP12 + DMS)
K252851 · Damae Medical · Oct 2025
HyperVue™ Software
K251198 · Spectrawave, Inc. · Jul 2025
OPUSWAVE Dual Sensor Imaging System
K250684 · Terumo Cardiovascular Systems Thi Plant · Jul 2025
OPXION Optical Skin Viewer (OPXSV1-01F)
K242924 · Opxion Technology, Inc. · Jun 2025